Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incidence of Ultrasonographically Detected Articular Damage in Initially Healthy Joints of Patients With Hemophilia A Receiving Prophylactic Treatment With Emicizumab. A Prospective Observational Study

NCT07420348 is registered in ClinicalTrials.gov with Investigación en Hemofilia y Fisioterapia as lead sponsor.

NCT NCT07420348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07420348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incidence of Ultrasonographically Detected Articular Damage in Initially Healthy Joints of Patients With Hemophilia A Receiving Prophylactic Treatment With Emicizumab. A Prospective Observational Study
Lead sponsor
Investigación en Hemofilia y Fisioterapia
Phase
Observational
Overall status
Not yet recruiting
Start date
February 27, 2026
Completion date
May 3, 2028
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia